Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SILK - Silk Road Medical Inc


IEX Last Trade
27.11
0.030   0.111%

Share volume: 845,343
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$27.08
0.03
0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
25%
Profitability 25%
Dept financing 20%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-0.48%
1 Month
0.26%
3 Months
31.73%
6 Months
53.25%
1 Year
33.35%
2 Year
-30.43%
Key data
Stock price
$27.11
P/E Ratio 
-19.48
DAY RANGE
N/A - N/A
EPS 
-$1.44
52 WEEK RANGE
$6.08 - $27.34
52 WEEK CHANGE
$0.38
MARKET CAP 
1.102 B
YIELD 
N/A
SHARES OUTSTANDING 
40.632 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
1.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$898,466
AVERAGE 30 VOLUME 
$1,262,065
Company detail
CEO: Erica Rogers
Region: US
Website: https://silkroadmed.com/
Employees: 362
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th

Recent news